You have 9 free searches left this month | for more free features.

City

Cleveland (1)

Houston (1)

Condition

Acute Myelogenous Leukemia (1)

Clear Cell Renal Cell Carcinoma (1)

Metastatic Cancer (1)

Pain (1)

Prostate Cancer (1)

Recurrent Renal Cell Cancer (1)

Stage IV Renal Cell Cancer (1)

Overall Status

Completed (2)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

Millennium Pharmaceuticals, Inc. (1)

Collaborator

Intervention

tandutinib (3)

laboratory biomarker analysis (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

NIH (2)

Industry (1)

Study Type

Interventional (3)

tandutinib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (tandutinib,

Completed

Has Results

Clear Cell Renal Cell Carcinoma
+2 more

tandutinib
laboratory biomarker analysis

Cleveland, Ohio

Case Western Reserve University

Oct 19, 2017

Metastatic Cancer, Pain, Prostate Cancer Trial in Houston (Tandutinib)

Completed

Has Results

Metastatic Cancer
+2 more

Tandutinib

Houston, Texas

M. D. Anderson Cancer Center at University of Texas

May 13, 2014

Acute Myelogenous Leukemia Trial (tandutinib)

Withdrawn

Acute Myelogenous Leukemia

tandutinib

(no location specified)

Nov 4, 2013